99% Anti- HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium

China 99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium, Find details about China Raltegravir, Raltegravir Powder from 99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium

Basic Info.

Model NO.

Condavo-Raltegravir

Name

Raltegravir

Product Name

Raltegravir Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

COA

Available

CAS

518048-05-0

444.41600

Density

1.46 g/cm3

Refractive Index

1.65

Grade

Medicine Grade

Psa

152.24000

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Raltegravir

Name

Raltegravir

Product Name

Raltegravir Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

COA

Available

CAS

518048-05-0

444.41600

Density

1.46 g/cm3

Refractive Index

1.65

Grade

Medicine Grade

Psa

152.24000

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

99% Anti-HIV Drugs Raltegravir powder Raltegravir Intermediate Raltegravir Potassium

99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium

Product Name	Raltegravir
CAS	518048-05-0
Appearance	White crystalline powder
MF	C20H21FN6O5
MW	444.41600
Purity	99%
Shelf Life	2 Years

Raltegravir, also known as MK-0518, is an antiretroviral drug used to treat HIV infection. Raltegravir is a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1.

99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium

99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium Raltegravir binds to and inhibits integrase, an HIV enzyme that inserts viral genetic material into the genetic material of the infected human cell. Inhibition of integrase prevents insertion of HIV DNA into the human DNA genome, thus blocking HIV replication. It received approval by the U.S.
99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium

It can be combined with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) -1 infection. It slows down HIV-1 infection by inhibiting the HIV integrase required for viral replication.

99% Anti-HIV Drugs Raltegravir Powder Raltegravir Intermediate Raltegravir Potassium